Skeletal Unloading Causes Resistance of Osteoprogenitor Cells to Parathyroid Hormone and to Insulin-like Growth Factor-I
Open Access
- 1 January 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 14 (1) , 21-31
- https://doi.org/10.1359/jbmr.1999.14.1.21
Abstract
Skeletal unloading decreases bone formation and osteoblast number in vivo and decreases the number and proliferation of bone marrow osteoprogenitor (BMOp) cells in vitro. We tested the ability of parathyroid hormone (PTH) to stimulate BMOp cells in vivo by treating Sprague Dawley rats (n = 32) with intermittent PTH(1–34) (1 h/day at 8 μ g/100 g of body weight), or with vehicle via osmotic minipumps during 7 days of normal weight bearing or hind limb unloading. Marrow cells were flushed from the femur and cultured at the same initial density for up to 21 days. PTH treatment of normally loaded rats caused a 2.5‐fold increase in the number of BMOp cells, with similar increases in alkaline phosphatase (ALP) activity and mineralization, compared with cultures from vehicle‐treated rats. PTH treatment of hind limb unloaded rats failed to stimulate BMOp cell number, ALP activity, or mineralization. Hind limb unloading had no significant effect on PTH receptor mRNA or protein levels in the tibia. Direct in vitro PTH challenge of BMOp cells isolated from normally loaded bone failed to stimulate their proliferation and inhibited their differentiation, suggesting that the in vivo anabolic effect of intermittent PTH on BMOp cells was mediated indirectly by a PTH‐induced factor. We hypothesize that this factor is insulin‐like growth factor‐I (IGF‐I), which stimulated the in vitro proliferation and differentiation of BMOp cells isolated from normally loaded bone, but not from unloaded bone. These results suggest that IGF‐I mediates the ability of PTH to stimulate BMOp cell proliferation in normally loaded bone, and that BMOp cells in unloaded bone are resistant to the anabolic effect of intermittent PTH therapy due to their resistance to IGF‐I.Keywords
This publication has 37 references indexed in Scilit:
- Regional Responsiveness of the Tibia to Intermittent Administration of Parathyroid Hormone as Affected by Skeletal UnloadingJournal of Bone and Mineral Research, 1997
- Insulin-like growth factor-I mediates osteoclast-like cell formation stimulated by parathyroid hormoneJournal of Cellular Physiology, 1997
- Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.Journal of Clinical Investigation, 1997
- Space Flight and the Skeleton: Lessons for the EarthboundThe Endocrinologist, 1997
- Journal of Biological Chemistry, 1996
- Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the ratJournal of Bone and Mineral Research, 1996
- Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized ratsJournal of Bone and Mineral Research, 1996
- Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.Journal of Clinical Investigation, 1995
- Response of femoral neck to estrogen depletion and parathyroid hormone in aged ratsBone, 1995
- Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized ratsJournal of Bone and Mineral Research, 1990